HK1217516A1 - 與胰島素抗性進程相關的生物標誌物和其用途 - Google Patents

與胰島素抗性進程相關的生物標誌物和其用途

Info

Publication number
HK1217516A1
HK1217516A1 HK16105395.2A HK16105395A HK1217516A1 HK 1217516 A1 HK1217516 A1 HK 1217516A1 HK 16105395 A HK16105395 A HK 16105395A HK 1217516 A1 HK1217516 A1 HK 1217516A1
Authority
HK
Hong Kong
Prior art keywords
methods
same
insulin resistance
biomarkers related
resistance progression
Prior art date
Application number
HK16105395.2A
Other languages
English (en)
Inventor
Gall Walter
Edmond Cobb Jeffery
Lane Pappan Kirk
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Publication of HK1217516A1 publication Critical patent/HK1217516A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
HK16105395.2A 2013-01-31 2016-05-11 與胰島素抗性進程相關的生物標誌物和其用途 HK1217516A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361758924P 2013-01-31 2013-01-31
PCT/US2014/011759 WO2014120449A1 (en) 2013-01-31 2014-01-16 Biomarkers related to insulin resistance progression and methods using the same

Publications (1)

Publication Number Publication Date
HK1217516A1 true HK1217516A1 (zh) 2017-01-13

Family

ID=51262841

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105395.2A HK1217516A1 (zh) 2013-01-31 2016-05-11 與胰島素抗性進程相關的生物標誌物和其用途

Country Status (6)

Country Link
US (2) US9910047B2 (zh)
EP (2) EP3321686B1 (zh)
JP (1) JP6404834B2 (zh)
ES (1) ES2669620T3 (zh)
HK (1) HK1217516A1 (zh)
WO (1) WO2014120449A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014243259B2 (en) * 2013-03-28 2019-04-18 Société des Produits Nestlé S.A. Indoxyl sulfate as a biomarker of prebiotic efficacy for weight gain prevention
CA2917483A1 (en) * 2013-07-09 2015-01-15 Stemina Biomarker Discovery, Inc. Biomarkers of autism spectrum disorder
EP3460478A4 (en) * 2016-05-17 2020-01-08 Osaka University METHOD AND SYSTEM FOR BLOOD SAMPLING FOR DETERMINING DIABETES
MX2018014867A (es) 2016-06-02 2019-03-07 Metabolon Inc Metodo de espectrometria de masa para deteccion y cuantificacion de metabolitos.
CN110088615B (zh) * 2016-12-19 2023-08-22 梅塔博隆股份有限公司 用于肾功能代谢物的检测和定量的质谱法测定方法
WO2018150077A1 (en) * 2017-02-16 2018-08-23 Afekta Technologies Oy Betaine biomarkers for nutritional status, nutritional regimen, endogenous metabolism, or risk of cardiovascular or metabolic diseases
MX2019011775A (es) * 2017-03-31 2020-02-05 Quest Diagnostics Invest Llc Metodos para la cuantificacion de insulina y peptido c.
EP3401683A1 (en) * 2017-05-10 2018-11-14 Eberhard Karls Universität Tübingen Medizinische Fakultät Diagnosing metabolic disease by the use of a biomarker
US11041847B1 (en) 2019-01-25 2021-06-22 Ixcela, Inc. Detection and modification of gut microbial population
KR102231928B1 (ko) * 2019-09-19 2021-03-26 고려대학교 산학협력단 비만대사수술 이후 당뇨병 예후 예측용 바이오마커 조성물
WO2021222309A1 (en) * 2020-04-27 2021-11-04 Ixcela, Inc. Detection and modification of gut microbial population
CN112149311B (zh) * 2020-10-12 2021-10-26 北京中恒利华石油技术研究所 一种基于数量规约的非线性多元统计回归测井曲线预测方法
CN112843036A (zh) * 2021-01-29 2021-05-28 中国药科大学 β-羟基丙酮酸在制备人胰岛淀粉样多肽聚集抑制剂中的应用
CN116087487A (zh) * 2021-11-08 2023-05-09 中国医学科学院阜外医院 糖尿病患者早期预测心血管疾病（cvd）的生物标志物及其用途
CN114324662B (zh) * 2021-12-30 2022-09-16 中南大学 用于诊断或预防糖尿病的血清生物标志物的应用
WO2023194615A1 (en) * 2022-04-07 2023-10-12 Need4Health B.V. Method for determining insulin dosage

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285092A4 (en) 2000-04-14 2003-07-16 Metabolon Inc METHOD FOR DISCOVERY OF MEDICINES, DISEASE TREATMENT AND DIAGNOSIS USE THE METABOLOMICS
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
WO2005094200A2 (en) * 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US7682782B2 (en) 2004-10-29 2010-03-23 Affymetrix, Inc. System, method, and product for multiple wavelength detection using single source excitation
US8119358B2 (en) 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
US8216847B2 (en) * 2006-03-24 2012-07-10 Metanomics Gmbh Means and method for predicting diabetes
MX341954B (es) * 2007-07-17 2016-09-08 Metabolon Inc Biomarcadores para prediabetes, enfermedades cardiovasculares y otros transtornos relacionados con sindrome metabolico, y metodos de uso de los mismos.
WO2010005982A2 (en) 2008-07-07 2010-01-14 The General Hospital Corporation Multiplexed biomarkers of insulin resistance
CA2727855A1 (en) * 2008-07-15 2010-01-21 Metanomics Health Gmbh Means and methods diagnosing gastric bypass and conditions related thereto
EP2414535A4 (en) * 2009-03-31 2012-12-26 Metabolon Inc BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHODS OF USE
US8367418B2 (en) 2009-10-23 2013-02-05 Therasyn Sensors, Inc. Method and system to provide personalized pharmaceutical compositions and dosages
US9217747B2 (en) * 2009-10-29 2015-12-22 Health Diagnostic Laboratory, Inc. Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
US20140303228A1 (en) * 2011-10-18 2014-10-09 Metabolon, Inc. Biomarkers for Amyotrophic Lateral Sclerosis and Methods Using the Same
JP2014533363A (ja) * 2011-11-11 2014-12-11 メタボロン，インコーポレイテッド 膀胱癌のバイオマーカーおよびそれを用いる方法
AU2012347557A1 (en) * 2011-12-09 2014-07-03 Metabolon, Inc. Biomarkers for kidney cancer and methods using the same

Also Published As

Publication number Publication date
JP6404834B2 (ja) 2018-10-17
US20180203021A1 (en) 2018-07-19
EP3321686B1 (en) 2024-03-13
EP2951313A4 (en) 2016-11-02
US20150362510A1 (en) 2015-12-17
EP2951313B1 (en) 2018-03-07
ES2669620T3 (es) 2018-05-28
EP3321686A1 (en) 2018-05-16
EP2951313A1 (en) 2015-12-09
WO2014120449A1 (en) 2014-08-07
JP2016509222A (ja) 2016-03-24
US9910047B2 (en) 2018-03-06

Similar Documents

Publication Publication Date Title
IL261743B (en) and their uses 33–il antibodies against
HK1217516A1 (zh) 與胰島素抗性進程相關的生物標誌物和其用途
HK1222905A1 (zh) 與腎功能相關的生物標記及其使用方法
IL261547B (en) Antibodies against pesidine and their uses
HK1214969A1 (zh) 抗- -β抗體及其使用
HK1218386A1 (zh) 生物光子材料及其用途
HK1218329A1 (zh) 型糖尿病生物標誌物及其用途
IL243974A0 (en) Antibodies against -prlr and uses
ZA201508896B (en) Anti-c10orf54 antibodies and uses thereof
SG11201509116VA (en) Anti-tweakr antibodies and uses thereof
GB201305277D0 (en) Novel combination and use
EP2988742A4 (en) THIAZOLES AND USES THEREOF
EP2985314A4 (en) CONTACT ELEMENT AND STRUCTURE CONTAINING THE CONTACT ELEMENT
GB201307989D0 (en) Novel combinations and use
SG11201600737TA (en) Instrument changing assembly and methods
GB201320992D0 (en) Complex and uses thereof
GB201315747D0 (en) Biomarkers associated with diabetes and firosis
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201311696D0 (en) Assembly and methods
GB201322146D0 (en) Improvements in frying technology
TWM475434U (en) Fettering structure with carrying handle and assembly thereof
GB201301393D0 (en) Kiddibidet and pottibidet
GB201301922D0 (en) Resistance